1,086
Participants
Start Date
November 30, 2000
Primary Completion Date
January 31, 2015
Study Completion Date
August 31, 2016
Cyclophosphamide
50 mg/day orally continuously for 1 year
Methotrexate
2.5 mg twice/day orally days 1 and 2 of every week for 1 year
Christchurch Hospital, Christchurch
Fundacion Arturo Lopez Perez, Santiago
Instituto Nacional de Enfermedades Neoplasicas, Lima
National Institute of Oncology - Budapest, Budapest
Sandton Oncology Centre, Johannesburg
Tweed Heads Hospital, Tweed Heads
Box Hill Hospital, Box Hill
Maroondah Hospital, East Ringwood
Institutul Oncologic - Universitatea de Medicina, Cluj-Napoca
Regionalspital, Thun
Murray Valley Private Hospital and Cancer Treatment Centre, Wodonga
FMH Onkologie/Haematologie, Rheinfelden
Queen Elizabeth Hospital, Adelaide
Ospedale degli Infermi - ASL 12, Biella
European Institute of Oncology, Milan
Ospedale San Paolo, Milan
Ospedale Alessandro Manzoni, Lecco
Ospedali Riuniti di Bergamo, Bergamo
Policlinico Universitario Udine, Udine
Azienda Ospedaliera di Padova, Padua
Ospedale Civile Ramazzini, Carpi
Ospedale Civile Rimini, Rimini
CHU Liege - Domaine Universitaire du Sart Tilman, Liège
Hospital de Clinicas de Porto Alegre, Porto Alegre
Centro de Estudios Oncologicos Santiago, Santiago
Hospital Clinico San Borja Arriaran, Santiago
Hospital Clinico Universidad de Chile, Santiago
Hospital Carlos Van Buren, Valparaíso
University of Ibadan Health Center, Ibadan
Ospedale Sant' Eugenio, Rome
Kantonsspital Aarau, Aarau
Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni, Bellinzona
Inselspital Bern, Bern
Kantonsspital Graubuenden, Chur
Kantonsspital - St. Gallen, Sankt Gallen
UniversitaetsSpital Zuerich, Zurich
ETOP IBCSG Partners Foundation
NETWORK